138 related articles for article (PubMed ID: 35596983)
1. In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
Aono A; Murase Y; Chikamatsu K; Igarashi Y; Shimomura Y; Hosoya M; Osugi A; Morishige Y; Takaki A; Yamada H; Mitarai S
Diagn Microbiol Infect Dis; 2022 Jul; 103(3):115714. PubMed ID: 35596983
[TBL] [Abstract][Full Text] [Related]
2. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex.
Marfil E; Ruiz P; Martínez-Martínez L; Causse M
J Glob Antimicrob Resist; 2022 Sep; 30():395-398. PubMed ID: 35863729
[TBL] [Abstract][Full Text] [Related]
4.
Ruiz P; Causse M; Vaquero M; Casal M
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670412
[TBL] [Abstract][Full Text] [Related]
5.
Shoen C; DeStefano M; Hafkin B; Cynamon M
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784848
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.
Rodríguez-Avial I; Culebras E; Betriu C; Morales G; Pena I; Picazo JJ
J Antimicrob Chemother; 2012 Jan; 67(1):167-9. PubMed ID: 21954458
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
[TBL] [Abstract][Full Text] [Related]
8. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
[TBL] [Abstract][Full Text] [Related]
10. Comparative
Wang S; Li Y; Xue F; Liu J; Yang W; Zhang J; Glenschek-Sieberth M; Lyu Y
J Chemother; 2019 Oct; 31(6):313-319. PubMed ID: 31215343
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China.
Wen S; Gao X; Zhao W; Huo F; Jiang G; Dong L; Zhao L; Wang F; Yu X; Huang H
Int J Infect Dis; 2021 Aug; 109():253-260. PubMed ID: 34216736
[TBL] [Abstract][Full Text] [Related]
12. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of tedizolid against 43 species of Nocardia species.
Toyokawa M; Ohana N; Tanno D; Imai M; Takano Y; Ohashi K; Yamashita T; Saito K; Takahashi H; Shimura H
Sci Rep; 2024 Mar; 14(1):5342. PubMed ID: 38438563
[TBL] [Abstract][Full Text] [Related]
14. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
[TBL] [Abstract][Full Text] [Related]
15. Determination of in vitro synergy between linezolid and other antimicrobial agents against Mycobacterium tuberculosis isolates.
Zou L; Liu M; Wang Y; Lu J; Pang Y
Tuberculosis (Edinb); 2015 Dec; 95(6):839-842. PubMed ID: 26395151
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.
Ahmed I; Jabeen K; Inayat R; Hasan R
Antimicrob Agents Chemother; 2013 Jun; 57(6):2522-5. PubMed ID: 23507286
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.
Huang TS; Liu YC; Sy CL; Chen YS; Tu HZ; Chen BC
Antimicrob Agents Chemother; 2008 Jun; 52(6):2226-7. PubMed ID: 18391030
[TBL] [Abstract][Full Text] [Related]
18. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
20. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
